|
GTEX-1GTWX
|
61-70
|
Male
|
GTEX-1GTWX-0726 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no abnormalitites, focal adhereant fat, delineated
|
Acceptable
|
 |
|
GTEX-1GTWX
|
61-70
|
Male
|
GTEX-1GTWX-3126 |
Pituitary gland
|
PAXgene |
1
|
1 piece, mainly adenohypophysis; ~2mm nubbin of neurohypophysis, delineated
|
Acceptable
|
 |
|
GTEX-1GZ2Q
|
41-50
|
Male
|
GTEX-1GZ2Q-0826 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; small ~ 1mm in diameter well circumscribed likely adenomatous nodule (outlined), some interstitial fibrosis, variably sized follicles
|
Acceptable
|
 |
|
GTEX-1GZ2Q
|
41-50
|
Male
|
GTEX-1GZ2Q-3126 |
Pituitary gland
|
PAXgene |
2
|
1 piece; predominantly adenohypophysis and tiny focus of neurohypohysis (outlined)
|
Acceptable
|
 |
|
GTEX-1GZ4H
|
41-50
|
Female
|
GTEX-1GZ4H-0226 |
Thyroid gland
|
PAXgene |
1
|
2 pieces: 1 with 40% oncocytic change [labeled], other with 5% and with 50% large blood vessels and stroma
|
Acceptable
|
 |
|
GTEX-1GZ4I
|
51-60
|
Male
|
GTEX-1GZ4I-0626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; well trimmed
|
Acceptable
|
 |
|
GTEX-1GZ4I
|
51-60
|
Male
|
GTEX-1GZ4I-3126 |
Pituitary gland
|
PAXgene |
1
|
1 pieces; posterior lobe comprises <10%
|
Acceptable
|
 |
|
GTEX-1GZHY
|
51-60
|
Female
|
GTEX-1GZHY-1426 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
|
GTEX-1GZHY
|
51-60
|
Female
|
GTEX-1GZHY-3226 |
Pituitary gland
|
PAXgene |
2
|
1 piece, ~40% neurohypophysis (delineated); rest moderatey autolyzed adenohypophysis
|
Acceptable
|
 |
|
GTEX-1H11D
|
41-50
|
Male
|
GTEX-1H11D-0626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; one piece includes ~10% fat/vessels, some regressive changes
|
Acceptable
|
 |
|
GTEX-1H1CY
|
61-70
|
Female
|
GTEX-1H1CY-0726 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; some areas are severely autolyzed
|
Acceptable
|
 |
|
GTEX-1H1CY
|
61-70
|
Female
|
GTEX-1H1CY-3126 |
Pituitary gland
|
PAXgene |
2
|
1 fragmented piece
|
Acceptable
|
 |
|
GTEX-1H1DE
|
21-40
|
Male
|
GTEX-1H1DE-0226 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
|
GTEX-1H1DF
|
41-50
|
Female
|
GTEX-1H1DF-1026 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; well dissected
|
Acceptable
|
 |
|
GTEX-1H1DF
|
41-50
|
Female
|
GTEX-1H1DF-3126 |
Pituitary gland
|
PAXgene |
2
|
1 piece; neurohypophysis (circled) makes up about 30%
|
Acceptable
|
 |
|
GTEX-1H1DG
|
61-70
|
Male
|
GTEX-1H1DG-0726 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no abnormalities
|
Acceptable
|
 |
|
GTEX-1H1DG
|
61-70
|
Male
|
GTEX-1H1DG-3026 |
Pituitary gland
|
PAXgene |
1
|
1 piece, adenohypophysis
|
Acceptable
|
 |
|
GTEX-1H1E6
|
21-40
|
Male
|
GTEX-1H1E6-0326 |
Thyroid gland
|
PAXgene |
0
|
2 pieces; trivial attachment of fibrous tissue/skeletal muscle
|
Acceptable
|
 |
|
GTEX-1H1ZS
|
61-70
|
Male
|
GTEX-1H1ZS-0726 |
Thyroid gland
|
PAXgene |
1
|
2 pieces. Nodular goiter; lymphocytic/Hashimoto thyroiditis, lymphoid aggregates delineated
|
Acceptable
|
 |
|
GTEX-1H1ZS
|
61-70
|
Male
|
GTEX-1H1ZS-3126 |
Pituitary gland
|
PAXgene |
1
|
2 pieces, one adenohypophysis (ensquared); one extra fragment of dura--ignore
|
Acceptable
|
 |
|
GTEX-1H23P
|
61-70
|
Male
|
GTEX-1H23P-0926 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; well dissected
|
Acceptable
|
 |
|
GTEX-1H23P
|
61-70
|
Male
|
GTEX-1H23P-2326 |
Prostate
|
PAXgene |
1
|
2 pieces; larger piece has <5% gland content, remainder is fibromuscular; other has <5% glands, 30% skeletal muscle diffusely distributed
|
Acceptable
|
 |
|
GTEX-1H23P
|
61-70
|
Male
|
GTEX-1H23P-3026 |
Pituitary gland
|
PAXgene |
1
|
1 piece; posterior lobe comprises 20% [labeled]
|
Acceptable
|
 |
|
GTEX-1H2FU
|
61-70
|
Female
|
GTEX-1H2FU-0626 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; nodular hyperplasia with regressive changes, adenomatoid nodules, attachment of skeletal muscle on one piece
|
Acceptable
|
 |
|
GTEX-1H2FU
|
61-70
|
Female
|
GTEX-1H2FU-3226 |
Pituitary gland
|
PAXgene |
1
|
1 piece; adenohypophysis
|
Acceptable
|
 |